Patents Assigned to Smith Kline & French Laboratories Limited
  • Fused thiadiazines
    Patent number: 4616013
    Abstract: This invention relates to thiadiazinone derivatives which have inotropic and vasodilator activity. A specific compound of this invention is 7-acetamido-9,9a-dihydroindeno[1,2-e][1,3,4]thiadiazine-2(3H)-one.
    Type: Grant
    Filed: November 6, 1984
    Date of Patent: October 7, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: William J. Coates
  • Substituted aminopyridones having histamine H.sub.2 -receptor blocking activity
    Patent number: 4608380
    Abstract: This invention relates to 2-substituted aminopyridone compounds which have histamine H.sub.2 -antagonist activity.
    Type: Grant
    Filed: November 28, 1984
    Date of Patent: August 26, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Thomas H. Brown
  • 3-(2-pyridylaminoalkylamino)thiazoles useful as histamine H.sub.1 -antagonists
    Patent number: 4607106
    Abstract: Pyridine derivatives are disclosed which are useful as histamine H.sub.1 -antagonists.
    Type: Grant
    Filed: May 17, 1985
    Date of Patent: August 19, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Robert J. Ife
  • 5-(Nitro or halogen)-3-(alkyl)-2-(aminoalkyl)pyridines
    Patent number: 4584381
    Abstract: Compounds of the formula: ##STR1## where R.sup.1 is halogen or nitro; R.sup.2 is C.sub.1-4 alkyl; and R.sup.3 is a C.sub.1-3 alkylene group are intermediates to 2-(3,5-disubstituted pyridyl-alkyl amino)-5-pyridylmethyl-4-pyrimidone derivatives which are useful as histamine H.sub.1 -antagonists.
    Type: Grant
    Filed: September 17, 1984
    Date of Patent: April 22, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: George S. Sach
  • Nitro pyrroles
    Patent number: 4584384
    Abstract: 3-Nitro-2-substituted aminopyrroles are histamine H.sub.2 -receptor antagonists. The 2-position substituent is a fully-unsaturated heterocyclyl alkyl group preferably with alkyl group interrupted by sulfur or oxygen. The 4- and 5-positions of the pyrrole ring can also be substituted.
    Type: Grant
    Filed: August 6, 1984
    Date of Patent: April 22, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: Michael L. Roantree, Rodney C. Young
  • Pharmaceutical tablet
    Patent number: D283739
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: May 6, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D285259
    Type: Grant
    Filed: December 21, 1984
    Date of Patent: August 19, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D285363
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: August 26, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D285364
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: August 26, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D285490
    Type: Grant
    Filed: January 23, 1984
    Date of Patent: September 2, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D285491
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: September 2, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D285492
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: September 2, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D285493
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: September 2, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D285494
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: September 2, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D285729
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: September 16, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D286085
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: October 7, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D286086
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: October 7, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D286208
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: October 14, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D286449
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: October 28, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey
  • Pharmaceutical tablet
    Patent number: D286450
    Type: Grant
    Filed: December 28, 1984
    Date of Patent: October 28, 1986
    Assignee: Smith Kline & French Laboratories Limited
    Inventor: Geoffrey D. Tovey